What is the cost of Chronic Hepatitis B treatment in China?

Starting from $300 up to $800, depending on disease severity and treatment protocol. Contact our team for a personalized quote.

How soon can I start Chronic Hepatitis B treatment in China?

3-5 days. Urgent cases can often be accommodated sooner. We prioritize international patient scheduling.

How long does Chronic Hepatitis B treatment take?

Typical hospital stay is Annual maintenance. Total time in China depends on recovery phase and follow-up needs.

What is the recovery time for Chronic Hepatitis B treatment?

Recovery typically takes Ongoing. Our multidisciplinary team provides comprehensive post-operative care and 12-month remote follow-up.

How do I start Chronic Hepatitis B treatment with SSAnkang?

Simply submit your medical records via our website, WhatsApp, or email. Our specialist team will evaluate your case within 24-48 hours and provide a personalized treatment plan and cost estimate.

Gastroenterology & Hepatology

Chronic Hepatitis B

Tenofovir alafenamide (TAF) and entecavir antiviral therapy with surveillance for HCC.

Treatment Options

Recommended Centers

$300

Starting From

7-21 days

Typical Wait

Treatment Plans for Chronic Hepatitis B

Compare evidence-based options at top Chinese hospitals — transparent pricing, typical wait, and recovery time.

Flagship Plan

TAF Antiviral Therapy (Annual)

Daily TAF tablet with quarterly monitoring.

Wait Time

3-5 days

Hospital Stay

Annual maintenance

Recovery

Ongoing

Estimated Price

Approx. $400/year

View Detailed Introduction — Procedure, Price Comparison & More

Price Comparison: China vs. USA

🇨🇳 China

$300

🇺🇸 USA

$2,000+

Save up to $1,700 per treatment

Procedure Steps

Pre-op: HBV DNA + HBeAg/HBeAb + HBsAg + HBV genotype + LFTs + liver elastography

Baseline: fibrosis staging (transient elastography or biopsy)

Initiate tenofovir alafenamide (TAF) 25mg orally once daily

Monitor HBV DNA every 3 months × first year, then every 6 months

ALT monitoring every 3 months

Annual HCC surveillance: abdominal US + AFP

Renal function + bone health monitoring (BMD every 2 years)

Long-term: continue therapy indefinitely for most patients

What is TAF for Chronic HBV?

Tenofovir alafenamide is a newer prodrug of tenofovir with better renal and bone safety profiles than TDF. It suppresses HBV replication to undetectable levels in 95%+ of patients, preventing progression to cirrhosis and HCC.

Why China?

HBV capital: China has 86M chronic HBV carriers — top hepatology centers see more cases than any country
Cost: $35-$80/month (domestic/biosimilar) vs. $1,500-$2,200/month US branded
Comprehensive care: Integrated HCC surveillance + fibrosis monitoring
Pregnancy expertise: Mother-to-child transmission prevention protocols (gold standard)

Who is a candidate?

HBV DNA ≥20,000 IU/mL (HBeAg+) or ≥2,000 IU/mL (HBeAg−) with elevated ALT
Cirrhosis (treat regardless of HBV DNA/ALT level)
Immunosuppression or chemotherapy (prophylactic treatment)
Pregnant women at high-risk for vertical transmission (3rd trimester)

Outcomes

HBV DNA undetectable: 95%+ at 1 year. ALT normalization: 85-90%. HBeAg seroconversion: 10-15% annually. HBsAg loss (functional cure): 1-3% annually. HCC risk reduction: 50-70%.

Book Free Consultation WhatsApp

Prices are indicative ranges in USD based on partner hospital published rates. Final quote depends on your medical records and selected hospital — request a free personalized estimate.

Why China for Chronic Hepatitis B

World's largest HBV cohort. Generic TAF at fraction of US cost.

Recommended Hospitals for Chronic Hepatitis B

Hand-picked by case volume, outcomes, and international patient experience.

Shanghai

About Chronic Hepatitis B

Common Symptoms

Often asymptomatic
Fatigue
Jaundice (acute flare)
Cirrhosis complications

Common Causes

HBV infection
Vertical transmission

Diagnostic Methods

HBsAg, HBeAg
HBV DNA
LFT
FibroScan
Liver MRI

Evidence & Reference Standards

Our gastroenterology pathways align with international GI and hepatology societies:

ACG · United States

ACG Clinical Guidelines

Evidence-graded recommendations for IBD, IBS, GERD, hepatitis and colorectal screening applied to every GI plan we coordinate.

AGA · United States

American Gastroenterological Association Guidelines

Quality measures and clinical pathways for endoscopy and chronic GI disease referenced in our pre-procedure briefing.

WGO · World Gastroenterology Organisation

WGO Global Guidelines

Resource-stratified international guidelines — used to cross-check that recommended Chinese-hospital protocols meet global standards.

Comparator · Reference

Mayo Clinic Gastroenterology

Top-ranked U.S. GI programme; our partner centres match endoscopy generations (Olympus EVIS X1) and ERCP/EUS capability at substantially lower cost.

SSAnkang Health is a medical-tourism coordination service; clinical procedures are performed by JCI-accredited Chinese hospitals. This page is for general information and does not constitute medical advice.

Related Conditions

Free Consultation

Get a personalized Chronic Hepatitis B treatment plan

Specialist review of your records within 24h
Matched to top hospitals & doctors
Transparent quote — no hidden fees
Visa, travel, and translation support

— or contact us directly —

WhatsApp +86 19392777259 Email Us

Confidential · No obligation · GDPR compliant